Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fine

Showing results (181-190 of 241) with videos related to

Pageof 25
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell CarcinomaMohammed Alghamdi, Jie-Fu Chen, Achim Jungbluth, et al.
Cancer Research|February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomyAnuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
The Journal of Pathology|October 31, 2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerP J Wild, J Giedl, R Stoehr, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
Pageof 25

Showing results (181-190 of 241) with videos related to

Sort By:
Pageof 25
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell CarcinomaMohammed Alghamdi, Jie-Fu Chen, Achim Jungbluth, et al.
Cancer Research|February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomyAnuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
The Journal of Pathology|October 31, 2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerP J Wild, J Giedl, R Stoehr, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
Pageof 25